Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure

BACKGROUND: The purpose of this study was to identify specific pharmacokinetic (PK) and pharmacodynamics (PD) factors that affect the likelihood of treatment remission with a serotonin norepinephrine reuptake inhibitor (SNRI) in depressed patients whose initial selective serotonin reuptake inhibitor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Affect Disord
Auteurs principaux: Ahmed, Ahmed T., Biernacka, Joanna M., Jenkins, Gregory, Rush, A John, Shinozaki, Gen, Veldic, Marin, Rung, Simon, Bobo, William V., Hall-Flavin, Daniel K., Weinshilboum, Richard M., Wang, Liewei, Frye, Mark A.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501809/
https://ncbi.nlm.nih.gov/pubmed/30578947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2018.12.021
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires